W. Schreml

797 total citations
46 papers, 561 citations indexed

About

W. Schreml is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, W. Schreml has authored 46 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in W. Schreml's work include Neutropenia and Cancer Infections (6 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (3 papers). W. Schreml is often cited by papers focused on Neutropenia and Cancer Infections (6 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (3 papers). W. Schreml collaborates with scholars based in Germany, United States and Austria. W. Schreml's co-authors include Hans‐Peter Lohrmann, P. Schlag, Edward R. Burka, H. Heimpel, Theodor M. Fliedner, W. D. Hetzel, H.G. Opitz, Hilmar Lemke, H. -P. Lohrmann and Guy Hewlett and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Biochemistry.

In The Last Decade

W. Schreml

42 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Schreml Germany 12 178 161 109 104 77 46 561
Daniel G. Miller United States 11 220 1.2× 129 0.8× 37 0.3× 74 0.7× 92 1.2× 23 661
M Musset France 14 332 1.9× 138 0.9× 80 0.7× 86 0.8× 57 0.7× 46 629
Н И Переводчикова United Kingdom 5 130 0.7× 121 0.8× 82 0.8× 64 0.6× 122 1.6× 15 429
H Yaneva France 11 67 0.4× 157 1.0× 50 0.5× 65 0.6× 54 0.7× 19 664
Chabner Ba United States 10 238 1.3× 132 0.8× 48 0.4× 56 0.5× 36 0.5× 21 483
Anna Sieńko United States 19 141 0.8× 163 1.0× 48 0.4× 234 2.3× 147 1.9× 32 770
E. E. Holdener Switzerland 10 187 1.1× 255 1.6× 51 0.5× 128 1.2× 48 0.6× 16 611
S Mancuso Italy 16 174 1.0× 110 0.7× 41 0.4× 77 0.7× 208 2.7× 51 966
S. Paul Perry United States 9 117 0.7× 142 0.9× 81 0.7× 81 0.8× 26 0.3× 11 479
João Soares Nunes Brazil 11 149 0.8× 202 1.3× 36 0.3× 57 0.5× 71 0.9× 21 468

Countries citing papers authored by W. Schreml

Since Specialization
Citations

This map shows the geographic impact of W. Schreml's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Schreml with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Schreml more than expected).

Fields of papers citing papers by W. Schreml

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Schreml. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Schreml. The network helps show where W. Schreml may publish in the future.

Co-authorship network of co-authors of W. Schreml

This figure shows the co-authorship network connecting the top 25 collaborators of W. Schreml. A scholar is included among the top collaborators of W. Schreml based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Schreml. W. Schreml is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kreuser, E.D., et al.. (2008). Fibrinpleurodese bei malignen Pleuraergüssen. DMW - Deutsche Medizinische Wochenschrift. 110(36). 1365–1368.
2.
Schreml, W., et al.. (2000). Integrated palliative care within a general hospital. Supportive Care in Cancer. 8(2). 80–83. 6 indexed citations
3.
Drings, P., I Günther, U. Gatzemeier, et al.. (1992). Final Evaluation of a Phase II Study on the Effect of Edelfosine (an Ether Lipid) in Advanced Non-Small-Cell Bronchogenic Carcinoma. Oncology Research and Treatment. 15(5). 375–382. 17 indexed citations
4.
Porzsolt, Franz, et al.. (1989). Compliance of physicians and patients with a consensus protocol for treatment of advanced breast cancer. Journal of Cancer Research and Clinical Oncology. 115(6). 564–570. 4 indexed citations
5.
Porzsolt, Franz, D. Messerer, Richard E. Hautmann, et al.. (1988). Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. Journal of Cancer Research and Clinical Oncology. 114(1). 95–100. 31 indexed citations
6.
Lohrmann, Hans‐Peter, et al.. (1982). 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.. PubMed. 68(4). 541–7. 9 indexed citations
7.
Betzler, Monika, W. Schreml, H. -P. Lohrmann, et al.. (1982). Adjuvant Intermittent Chemoimmunotherapy for Primary Breast Cancer: A Prospective Study with Immunologic Follow-Up. Recent results in cancer research. 80. 185–191. 7 indexed citations
8.
Schlag, P., W. Schreml, Wilhelm Gaus, et al.. (1982). Adjuvant 5-Fluorouracil and BCNU Chemotherapy in Gastric Cancer: 3-Year Results. Recent results in cancer research. 80. 277–283. 22 indexed citations
9.
Schreml, W., et al.. (1981). [Drug therapy for pain in cancer patients].. PubMed. 76(2). 43–7. 3 indexed citations
10.
Lohrmann, Hans‐Peter & W. Schreml. (1979). Sensitivity of human granulopoiesis in vitro to adriamycin before and after exposure in vivo.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(2 Pt 1). 527–30. 2 indexed citations
11.
Schreml, W. & H. -P. Lohrmann. (1979). No effects of levamisole on cytotoxic drug-induced changes of human granulopoiesis. Annals of Hematology. 38(4). 331–336. 5 indexed citations
12.
Lohrmann, Hans‐Peter, W. Schreml, Theodor M. Fliedner, & H. Heimpel. (1979). Reaction of human granulopoiesis to high-dose cyclophosphamide therapy. Annals of Hematology. 38(1). 9–16. 30 indexed citations
13.
Schreml, W., et al.. (1978). PROGRESSIVE PULMONARY FIBROSIS DURING COMBINATION CHEMOTHERAPY WITH BCNU. Annals of Hematology. 36(6). 353–356. 3 indexed citations
14.
Schreml, W., et al.. (1978). Progrediente Lungenfibrose unter Kombinationstherapie mit BCNU. Annals of Hematology. 36(6). 353–356. 5 indexed citations
15.
Schreml, W. & Fliedner Tm. (1978). Distribution of tritiated compounds (tritiated thymidine and tritiated water) in the mother-fetus system and its consequences for the radiotoxic effect of tritium.. PubMed. 12(1-4). 255–77. 10 indexed citations
16.
Opitz, H.G., Uta Opitz, Hilmar Lemke, et al.. (1977). The role of fetal calf serum in the primary immune response in vitro.. The Journal of Experimental Medicine. 145(4). 1029–1038. 55 indexed citations
17.
Haas, Rainer & W. Schreml. (1974). Die Wirkung von Tritium-Wasser auf die Entwicklung der fetalen Hämopoese der Ratte. Annals of Hematology. 29(2). 96–107. 1 indexed citations
18.
Bremer, K., et al.. (1974). Chronic lymphoid leukemia: concentration of normal lymphocytes in the lymph.. PubMed. 21(9). 361–4. 1 indexed citations
19.
Schreml, W. & Edward R. Burka. (1968). Properties of Membrane-bound Ribosomes in Reticulocytes. Journal of Biological Chemistry. 243(13). 3573–3580. 32 indexed citations
20.
Burka, Edward R., et al.. (1967). Membrane-Bound Ribonucleic Acid in Mammalian Erythroid Cells*. Biochemistry. 6(9). 2840–2847. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel G. Miller Breakdown of academic impact, for papers by M Musset Breakdown of academic impact, for papers by Н И Переводчикова Breakdown of academic impact, for papers by H Yaneva Breakdown of academic impact, for papers by Chabner Ba Breakdown of academic impact, for papers by Anna Sieńko Breakdown of academic impact, for papers by E. E. Holdener Breakdown of academic impact, for papers by S Mancuso Breakdown of academic impact, for papers by S. Paul Perry Breakdown of academic impact, for papers by João Soares Nunes
Rankless by CCL
2026